Toward 2030: Collaborative Solutions for Hepatitis C Diagnosis, Care, and Elimination

Nov 10 2025
Convention Center: Ballroom C, Level 3
5:00 PM - 6:30 PM

World Class Speakers

Deirdre A Kelly, MD, FAASLD
Abstract Presenter

Deirdre A Kelly, MD, FAASLD

University of Birmingham
Scott J. Cotler, MD, MD, FAASLD
Moderator

Scott J. Cotler, MD, MD, FAASLD

Loyola University Health System
Gia Landry, MD, MPH
Moderator

Gia Landry, MD, MPH

LSU Health Sciences Center

Description

This session presents innovative and collaborative approaches to achieving global Hepatitis C elimination for adults and children. Presenters will share insights on diagnostic strategies, care linkage, and progress toward the WHO 2030 targets, highlighting efforts across clinical, public health, and global contexts.

Journey Maps

Presentations

5:00 PM - 5:15 PM
Apr 29 2026
Washington, D.C.

How collaborative working will achieve the WHO Target -to eliminate Hepatitis C Virus (HCV) in children and young people by 2030

Deirdre A Kelly, MD, FAASLD , Abstract Presenter
Hepatitis

Objectives

  • Describe innovative strategies and technologies that enhance HCV testing, diagnosis, and linkage to care across diverse populations and settings.
  • Discuss the role of cross-sector collaboration and global monitoring frameworks in advancing the WHO goal of HCV elimination by 2030.
  • Describe partnerships between healthcare systems, community organizations, and international coalitions.
  • Identify barriers and opportunities in achieving HCV elimination among children, youth, and underserved communities.